AplusB: A web application for investigating A + B designs for phase I cancer clinical trials

12Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

In phase I cancer clinical trials, the maximum tolerated dose of a new drug is often found by a dose-escalation method known as the A + B design. We have developed an interactive web application, AplusB, which computes and returns exact operating characteristics of A + B trial designs. The application has a graphical user interface (GUI), requires no programming knowledge and is free to access and use on any device that can open an internet browser. A customised report is available for download for each design that contains tabulated operating characteristics and informative plots, which can then be compared with other dose-escalation methods. We present a step-by-step guide on how to use this application and provide several illustrative examples of its capabilities.

Cite

CITATION STYLE

APA

Wheeler, G. M., Sweeting, M. J., & Mander, A. P. (2016). AplusB: A web application for investigating A + B designs for phase I cancer clinical trials. PLoS ONE, 11(7). https://doi.org/10.1371/journal.pone.0159026

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free